Location: Home
  • search
  • go
  • Relate News
  • 2/27/2026Evopoint Biosciences Highlights Igermetostat Data at ASCO GU 2026 in m...
  • 2/27/2026Duality Reports Updated DB-1311/BNT324 Data at ASCO GU 2026
  • 2/27/2026CSPC Launches Phase III Program for SYH2053 PCSK9 siRNA in China
  • 2/26/2026China Accelerates Dementia Research to Challenge U.S. Leadership
  • 2/26/2026Pfizer Updates Pneumococcal Vaccine Trial in China, Implications for I...
  • 2/26/2026Jiuyuan Files for Approval of Wegovy Biosimilar in China
  • 2/26/2026China Pharmaceutical Market Projected to Reach US$573B by 2033
  • 2/26/2026Health Guard's Trial Suspensions Deepen Pressure on China's HPV Vaccin...
  • 2/26/2026U.S. ITC to Probe China's Trade Status and Biotech Practices
  • 2/26/2026China Expands Mutual Recognition of Medical Tests to Streamline Care a...
  • 2/26/2026China's Biopharma Boom Attracts Global Investment Amid Innovation Surg...
  • 2/26/2026BMS-Partnered Bispecific ADC Achieves Dual Survival Milestones in Chin...
  • 2/26/2026China's Healthcare Reform Playbook: Boosting Births and Opening the Do...
  • 2/25/2026The Patent Term Compensation and Protection Scope in the Compensated P...
  • 2/25/2026Global Pharma Giants Rush to License Chinese Weight-Loss Drugs, Eye Ob...
  • 2/25/2026China Outpaces US and EU in Drug R&D with Faster Trials and Lower Cost...
  • 2/25/2026Henlius Expands Global Footprint with Exclusive Abbott Licensing Deal ...
  • 2/25/2026Slate Medicines Launches With $130M to Advance China-Licensed PACAP Mi...
  • 2/25/2026Prodegre Closes Angel+ Round to Advance CNS Pipeline and ATLAS™ Platf...
  • 2/25/2026Kelun-Biotech's sac-TMT OS Data Selected as Late-Breaker at ELCC 2026
  • 2/25/2026CDE Solicits Comments on Batch 104 of Chemical Generic Reference Formu...
  • 2/25/2026CASI Pharma to Be Delisted from Nasdaq, Shares to Move to OTC Market
  • 2/25/2026CStone Secures UK Approval for Sugemalimab in Stage III NSCLC
  • 2/25/2026China Schedules Antitrust Hearing in Abuse‑of‑Dominance Case Tied to...
  • 2/24/2026Pfizer Acquires China Rights to Sciwind's Approved GLP-1 Therapy
  • 2/24/2026United Labs and Novo Nordisk Post Strong Phase 2 Data for UBT251 Tripl...
  • 2/24/2026XtalPi and YolTech Forge AI Alliance to Advance mRNA and In Vivo CAR-T...
  • 2/24/2026Frontier Biotech Inks Global siRNA Licensing Deal with GSK
  • 2/24/2026Harbour BioMed Strikes $1.1B-Plus Ex-China Deal for Anti-CTLA-4 Antibo...
  • 2/24/2026Ascentage Registers U.S. Phase 1 Trial for BTK PROTAC APG-3288
  • Page:10/828 Total number of articles:24826: [First][<<] [8] [9] [10] [11] [12] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group